跳至主要内容
临床试验/NCT04606511
NCT04606511Unknown不适用

Screening for Lymphedema

Odense University Hospital2 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2020年10月5日最近更新:
适应症

试验速览

阶段
不适用
入组人数
250
试验地点
2
主要终点
sensitivity, specificy, NPV and PPV

研究概览

简要总结

Breast cancer-related lymphedema is one of the most common and feared consequences of breast cancer treatment. Currently, there is no established screening program for lymphedema. This cross-sectional study will investigate diagnostic modalities in screening for lymphedema in patients with and without known lymphedema after breast cancer.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Previous breast cancer treated with axillary lymph node dissection
  • No recurrence
  • Understand the study
  • Can talk, read and understand Danish

排除标准

  • Pregnant or breast feeding
  • Lymph node dissection from other basins
  • Psychiatric disorder
  • Not possible to perform indocyanine green lymphangiography

结局指标

主要结局

sensitivity, specificy, NPV and PPV

时间窗: through study completion, approximately 1 year

diagnosotic statistics of lymphedema measurements

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mads Gustaf Jørgensen

Principal Investigator

Odense University Hospital

研究点 (2)

Loading locations...

相似试验